Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Brixner

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 6, 2008
Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record databaseDiana Brixner, Sameer R Ghate, Carrie McAdam-Marx, et al.
Journal of Managed Care & Specialty Pharmacy|July 27, 2019
Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast CancerJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.
American Health & Drug Benefits|July 4, 2014
Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging MarketsAnke-Peggy Holtorf, Diana Brixner, Brandon Bellows, et al.
The American Journal of Emergency Medicine|December 18, 2020
Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital systemTheodoros V Giannouchos, Joseph Biskupiak, Michael J Moss, et al.
Journal of Managed Care & Specialty Pharmacy|June 20, 2022
Advancing a managed care pharmacy research agenda: Generating real-world evidence to support US Food and Drug Administration Accelerated Approvals and improving benefit design to address health inequitiesDiana Brixner, Joe Couto, Karen Worley, et al.
The American Journal of Managed Care|January 23, 2016
Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillationSumesh Kachroo, Melissa Hamilton, Xianchen Liu, et al.
Journal of Managed Care & Specialty Pharmacy|June 27, 2017
A Retrospective, Longitudinal, Claims-Based Comparison of Concomitant Diagnoses Between Individuals with and Without Down SyndromeAmanda M Kong, Dana Hurley, Kristin A Evans, et al.
Journal of Pain & Palliative Care Pharmacotherapy|September 25, 2025
Characteristics and Economic Outcomes of Treated and Untreated Patients Diagnosed with Opioid Use DisorderHoward Weston Schmutz, Connor Willis, Emeka Elvis Duru, et al.
International Ophthalmology|August 22, 2023
Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping reviewAinhoa Gomez-Lumbreras, Priyanka Ghule, Rupesh Panchal, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 10, 2025
The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO studyDaniel C Malone, Roger Seheult, Diana Brixner, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Journal of Managed Care Pharmacy : JMCP|November 6, 2008
Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record databaseDiana Brixner, Sameer R Ghate, Carrie McAdam-Marx, et al.
Journal of Managed Care & Specialty Pharmacy|July 27, 2019
Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast CancerJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.
American Health & Drug Benefits|July 4, 2014
Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging MarketsAnke-Peggy Holtorf, Diana Brixner, Brandon Bellows, et al.
The American Journal of Emergency Medicine|December 18, 2020
Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital systemTheodoros V Giannouchos, Joseph Biskupiak, Michael J Moss, et al.
Journal of Managed Care & Specialty Pharmacy|June 20, 2022
Advancing a managed care pharmacy research agenda: Generating real-world evidence to support US Food and Drug Administration Accelerated Approvals and improving benefit design to address health inequitiesDiana Brixner, Joe Couto, Karen Worley, et al.
The American Journal of Managed Care|January 23, 2016
Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillationSumesh Kachroo, Melissa Hamilton, Xianchen Liu, et al.
Journal of Managed Care & Specialty Pharmacy|June 27, 2017
A Retrospective, Longitudinal, Claims-Based Comparison of Concomitant Diagnoses Between Individuals with and Without Down SyndromeAmanda M Kong, Dana Hurley, Kristin A Evans, et al.
Journal of Pain & Palliative Care Pharmacotherapy|September 25, 2025
Characteristics and Economic Outcomes of Treated and Untreated Patients Diagnosed with Opioid Use DisorderHoward Weston Schmutz, Connor Willis, Emeka Elvis Duru, et al.
International Ophthalmology|August 22, 2023
Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping reviewAinhoa Gomez-Lumbreras, Priyanka Ghule, Rupesh Panchal, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 10, 2025
The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO studyDaniel C Malone, Roger Seheult, Diana Brixner, et al.
Pageof 11